ADAGIO MEDICAL HOLDINGS, INC. Operating Cash Flow
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Operating Cash Flow of -$9.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$5.26M.
- ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.13M.
- ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.14M.
- ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.01M.
- ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$19.01M.
- ADAGIO MEDICAL HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$25.65M.
| Period end | Net Cash Provided by (Used in) Operating Activities 2 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 5 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$9.39M 10-Q · filed 2026-08-11 | -$13.52M derived: sum of 3 quarters · filed 2026-08-11 | -$16.53M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | -$4.13M 10-Q · filed 2026-05-12 | -$8.26M derived: sum of 2 quarters · filed 2026-05-12 | -$11.27M derived: sum of 3 quarters · filed 2026-05-12 | -$15.93M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | -$4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$7.15M derived: sum of 2 quarters · filed 2026-03-27 | -$11.80M derived: sum of 3 quarters · filed 2026-08-11 | -$19.01M 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | -$3.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$7.67M derived: sum of 2 quarters · filed 2026-08-11 | -$14.88M 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | -$4.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$11.87M 10-Q · filed 2026-08-11 | ||||||
| 2025-03-31 | -$7.21M 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | -$13.47M 10-K · filed 2026-03-27 | |||||||
| 2024-09-30 | -$6.36M 10-Q · filed 2025-11-12 | |||||||
| 2024-07-30 | -$15.99M 10-K · filed 2026-03-27 | |||||||
| 2024-06-30 | -$6.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$13.68M 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2024-08-26 | -$20.77M derived: sum of 3 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$6.74M 10-Q · filed 2025-05-15 | -$13.83M derived: sum of 2 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | -$7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$25.65M 10-K · filed 2025-03-27 | ||||||
| 2023-09-30 | -$18.56M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |